EGFR and hepatocellular carcinoma: The top eight anti-HCC core targets are SRC (degree 60), EGFR (degree 58), CASP3 (degree 57), MMP9 (degree 47), mTOR (degree 45), HIF1A (degree 43), ERBB2 (degree 42), and PPARG (degree 38).